EUROPEAN MEDICAL SOLUTIONS
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium and internationally. It offers R/F solutions, including PLATINUM NEO, a solution that revolutionizes the R/F workflow through an interface and AI-powered image processing; OPTIMA, a performance remote-controlled table designed to provid… Read more
EUROPEAN MEDICAL SOLUTIONS (ALEMS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.053x
Based on the latest financial reports, EUROPEAN MEDICAL SOLUTIONS (ALEMS) has a cash flow conversion efficiency ratio of 0.053x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€594.00K) by net assets (€11.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EUROPEAN MEDICAL SOLUTIONS - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how EUROPEAN MEDICAL SOLUTIONS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
EUROPEAN MEDICAL SOLUTIONS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EUROPEAN MEDICAL SOLUTIONS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
House of Jane Inc
PINK:HOJI
|
N/A |
|
LadRx Corporation
OTCQB:LADX
|
0.259x |
|
Daios Plastics S.A.
AT:DAIOS
|
N/A |
|
Tatton Asset Management plc
LSE:TAM
|
0.130x |
|
DENNY'S
BE:DE8
|
-0.120x |
|
WEWORK INDIA MANAGEMENT L
NSE:WEWORK
|
N/A |
|
CEBR6F
SA:CEBR6F
|
N/A |
|
Stcube
KO:052020
|
-0.296x |
Annual Cash Flow Conversion Efficiency for EUROPEAN MEDICAL SOLUTIONS (2013–2024)
The table below shows the annual cash flow conversion efficiency of EUROPEAN MEDICAL SOLUTIONS from 2013 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €10.34 Million | €2.56 Million | 0.247x | +207.50% |
| 2023-12-31 | €9.89 Million | €-2.27 Million | -0.230x | -216.86% |
| 2022-12-31 | €10.64 Million | €2.09 Million | 0.197x | +515.57% |
| 2021-12-31 | €10.89 Million | €348.00K | 0.032x | -86.92% |
| 2020-12-31 | €-5.63 Million | €-1.38 Million | 0.244x | -92.13% |
| 2019-12-31 | €-4.18 Million | €-12.97 Million | 3.107x | +254.36% |
| 2018-12-31 | €6.47 Million | €-13.02 Million | -2.013x | +81.20% |
| 2017-12-31 | €1.20 Million | €-12.84 Million | -10.705x | -926.32% |
| 2016-12-31 | €13.13 Million | €-13.70 Million | -1.043x | -111.30% |
| 2015-12-31 | €-858.00K | €-7.92 Million | 9.232x | +2150.60% |
| 2014-12-31 | €7.50 Million | €-3.38 Million | -0.450x | +99.10% |
| 2013-12-31 | €42.00K | €-2.11 Million | -50.286x | -- |